Private Equity Round - Launch Therapeutics

Private Equity Round - Launch Therapeutics

Investment Firm

Overview

Launch Therapeutics is a clinical development company that offers drug development, medical, clinical operations, and regulatory.

Announced Date

Apr 11, 2022

Funding Type

Private Equity

Highlights

Location

United States, North America

Social

Investor Lead

The Carlyle Group

The Carlyle Group

The Carlyle Group is a debt and early_stage_venture and late_stage_venture and private_equity firm.

Abingworth

Abingworth

Abingworth is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

2

Investor Name
Participant InvestorAbingworth
Participant InvestorThe Carlyle Group

Round Details and Background

Launch Therapeutics raised an undisclosed amount on 2022-04-11 in Private Equity Round

Launch Therapeutics is a clinical development company that offers drug development, medical, clinical operations, and regulatory.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 11, 2022
Private Equity Round - Launch Therapeutics
2-undefined

Recent Activity

There is no recent news or activity for this profile.